Angiogenic Factor-Driven Improvement of Refractory Thin Endometrium with Autologous Platelet-Rich Plasma Intrauterine Infusion in Frozen Embryo Transfer Cycles

    September 2024 in “ Frontiers in Endocrinology ”
    So Yeon Shin, Nanum Chung, Ji Eun Shin … Ji Hyang Kim
    Studysummary This study found that intrauterine PRP infusion is a safe and effective treatment for patients with refractory thin endometrium and implantation failures, with the improvement primarily driven by the angiogenic cytokines in PRP.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on frontiersin.org →
    Discuss this study in the Community →

    Research cited in this study 2

    1. Platelet-Rich Plasma: New Performance Understandings and Therapeutic Considerations in 2020 International Journal of Molecular Sciences · 2020
    2. A Review of the Treatment of Male Pattern Hair Loss Expert Opinion on Pharmacotherapy · 2020